Trust has received huge thanks from the team behind the national GenOMICC study
into Covid-19 and the effects on patients.
The GenOMICC team sent
an email to the Trust’s research team thanking them for their part in recruiting patients to
the study. It said: “Another busy week has
reached its end and the team here at GenOMICC would like to take this time to
say a big thank you for all the enthusiasm your team at Rotherham Hospital
has put into recruiting patients to the study. We are pleased to say that you
are in the top three of all the sites involved in the project in the past 14
days (of which there are over 200!). We really appreciate the effort! Thank you
Lead Research Nurse, said the GenOMICC study was ground-breaking research that
has the potential to dramatically improve our understanding of Covid-19.
She said: “It could help us to identify whether
underlying genomic differences play a part in how people react to the virus and
why some people have few or no symptoms, while others can get very ill.
“We approached patients who had been on
critical care with Covid-19 at TRFT and had an amazing response, with 10
patients contacting us in just a few days to participate.
“The data that is
collected during the study will also inform global strategic planning for
possible later waves of the pandemic, and for new pandemics in the future.”
As we’ve previously
reported, the Trust is one of the sites hosting the GenOMICC’s study sponsored
by the University of Edinburgh to sequence human genomes in the fight against
Covid-19. The study aims to sequence the genomes of 20,000 people who are
severely ill with Covid-19, and a further 15,000 individuals with mild
symptoms. The study will help us better understand the virus’ varied effects on
people and support the search for treatments.